Get started
BRIACELL THERAPEUTICS CORPBRIACELL THERAPEUTICS CORPBRIACELL THERAPEUTICS CORP

BRIACELL THERAPEUTICS CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BCT chart


Full chart

Key stats


Market capitalization
‪39.44 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.39 CAD
Net income (FY)
‪−6.51 M‬ CAD
Revenue (FY)
0.00 CAD
Shares float
‪32.50 M‬
Beta (1Y)
0.53

About BRIACELL THERAPEUTICS CORP


Sector
Health Technology
Industry
Biotechnology
CEO
William V. Williams
Website
briacell.com
Headquarters
West Vancouver
Founded
2006
FIGI
BBG000D9RW32
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BCT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where BCT is featured.

See all sparks 

Related symbols


CT1!
Cotton No. 2 Futures
CT2!
Cotton No. 2 Futures
COTUSD
CFDs on Cotton

Frequently Asked Questions


The current price of BCT is 1.01 CAD — it has increased by 0.92% in the past 24 hours. Watch BRIACELL THERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange BRIACELL THERAPEUTICS CORP stocks are traded under the ticker BCT.
BCT stock has risen by 30.95% compared to the previous week, the month change is a −10.57% fall, over the last year BRIACELL THERAPEUTICS CORP has showed a −83.97% decrease.
BCT reached its all-time high on May 2, 2011 with the price of 672.73 CAD, and its all-time low was 0.64 CAD and was reached on Sep 17, 2024. View more price dynamics on BCT chart.
See other stocks reaching their highest and lowest prices.
BCT stock is 14.58% volatile and has beta coefficient of 0.53. Track BRIACELL THERAPEUTICS CORP stock price on the chart and check out the list of the most volatile stocks — is BRIACELL THERAPEUTICS CORP there?
Today BRIACELL THERAPEUTICS CORP has the market capitalization of ‪39.44 M‬, it has increased by 31.33% over the last week.
Yes, you can track BRIACELL THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
BCT net income for the last quarter is ‪−1.66 M‬ CAD, while the quarter before that showed ‪2.33 M‬ CAD of net income which accounts for −171.40% change. Track more BRIACELL THERAPEUTICS CORP financial stats to get the full picture.
No, BCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIACELL THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIACELL THERAPEUTICS CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIACELL THERAPEUTICS CORP stock shows the sell signal. See more of BRIACELL THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.